CClinicalTrials.gg
RecruitingNCT06975033Updated Apr 16, 2026

Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP

An interventional study of Video in HoLEP, Patient Satisfaction and Educational Video Intervention, sponsored by University of California, San Francisco. Recruiting at 3 sites in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-16.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

This will be a randomized interventional study. Patients scheduled to undergo a HoLEP at UCSF will be randomized into two groups after the procedure: one group will watch a scripted educational HoLEP video and the other group will not receive a video. We will monitor the post-operative care utilization after discharge. Secondary outcomes will include patient satisfaction.

02

Conditions studied

  • HoLEP
  • Patient Satisfaction
  • Educational Video Intervention

Browse trials for

03

In context

Patient Satisfaction

256 studies on the registry are indexed under Patient Satisfaction; 127 are open to participants now.

This study's planned enrollment of 114 is above the median of 90 across 196 interventional studies indexed under Patient Satisfaction.

Browse Patient Satisfaction studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Adults aged 18+
  2. Patients scheduled for a HoLEP procedure
  3. Patients willing to complete both baseline and follow up surveys
  4. Patients able to provide informed consent
  5. Patients are English-speaking and understand English

Exclusion criteria

Exclusion Criteria:

  1. Patients under 18+
  2. Patients unable to consent
  3. Patients unable to complete surveys
  4. Patients without a prostate.
  5. Patients are non-English speakers
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    Video

    Participants will watch video.

    Other: Video

  • No intervention
    No Video

    Participants will not watch video.

Interventions

  • OtherVideo

    Participants will watch video.

06

What researchers measure

Primary outcomes

  1. Number of Post-operative Healthcare Utilization Events

    Healthcare utilization will include MyChart messages, phone calls to clinic, unscheduled clinic visits, hospital readmissions, and emergency/urgent care visits.

    Time frame: up to 90 days (estimated time frame between initial surgery and first follow up visit)

  2. Participant Satisfaction Score

    Measured using Likert scale survey ranging from 1 (strongly agree) to 5 (strongly disagree).

    Time frame: up to 90 days (estimated time frame between initial surgery and first follow up visit)

07

Study locations

1 of 3 sites recruiting
  • University of California, San Francisco
    San Francisco, California 94143, United States
    Recruiting
  • University of Rochester Medical Center
    Rochester, New York 14620, United States
    Not yet recruiting
  • Scott SUNY Upstate Medical University
    Syracuse, New York 13210, United States
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06975033
Lead sponsor
University of California, San Francisco
Collaborators
State University of New York - Upstate Medical University, University of Rochester
Responsible party
Sponsor
First posted
May 16, 2025
Start date
Nov 4, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 16, 2026

Study contacts

David Bayne, MD, MPH
Contact
david.bayne@ucsf.edu
617-571-5870
David Bayne, MD, MPH
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion